Detalhe da pesquisa
1.
Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression.
Br J Cancer
; 126(3): 401-408, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373567
2.
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.
BMC Cancer
; 18(1): 726, 2018 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986670
3.
Detection of metastases using circulating tumour DNA in uveal melanoma.
J Cancer Res Clin Oncol
; 149(16): 14953-14963, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608028
4.
Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.
Cancers (Basel)
; 13(23)2021 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885099
5.
Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression.
Cancers (Basel)
; 12(11)2020 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238616
6.
A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma.
Sci Rep
; 10(1): 6083, 2020 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32269293
7.
The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond BRAF Mutant Detection.
Cancers (Basel)
; 12(12)2020 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33339135
8.
Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies.
Oncotarget
; 11(44): 4016-4027, 2020 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216826
9.
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.
Clin Cancer Res
; 26(22): 5926-5933, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067256
10.
Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies.
Oncotarget
; 10(2): 113-122, 2019 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719207
11.
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma.
Mol Oncol
; 13(2): 171-184, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312528
12.
Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma.
JCO Precis Oncol
; 22018.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913999
13.
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and Pyrosequencing.
J Mol Diagn
; 20(2): 240-252, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305225
14.
Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma.
Oncotarget
; 8(45): 78890-78900, 2017 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29108273
15.
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.
Oncotarget
; 6(39): 42008-18, 2015 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26524482